UPDATED Aug 13, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
REGN | US$561.55 | 0.9% | -51.5% | US$57.7b | US$708.91 | PE13.1x | E5.6% | 0.6% | ||
CAI | US$34.28 | 5.6% | n/a | US$9.0b | US$39.38 | PS21.1x | E71.0% | n/a | ||
MRNA | US$26.89 | 4.8% | -67.3% | US$10.0b | US$44.86 | PS3.4x | E37.2% | n/a | ||
WST | US$246.22 | 2.6% | -15.7% | US$17.3b | US$316.36 | PE36.3x | E11.5% | 0.4% | ||
BNTX | US$112.78 | 1.6% | 32.9% | US$27.1b | US$137.82 | PS8.1x | E18.0% | n/a | ||
TLRY | US$1.25 | 31.5% | -35.9% | US$1.4b | n/a | PS1.7x | E141.3% | n/a | ||
UTHR | US$309.72 | 2.8% | -4.4% | US$13.6b | US$379.32 | PE11.3x | E8.3% | n/a | ||
RPRX | US$36.46 | 1.7% | 36.8% | US$20.9b | US$43.27 | PE15.4x | E7.2% | 2.4% | ||
RVTY | US$90.93 | 3.3% | -22.6% | US$10.2b | US$116.81 | PE37.9x | E23.4% | 0.3% | ||
ALNY | US$432.52 | 0.6% | 64.5% | US$56.4b | US$424.64 | PS23x | E54.1% | n/a | ||
RGEN | US$127.15 | 4.7% | -21.8% | US$7.2b | US$179.72 | PS10.6x | E44.7% | n/a | ||
APLS | US$26.58 | 11.2% | -26.2% | US$3.0b | US$37.74 | PS4.4x | E66.7% | n/a | ||
VTRS | US$10.41 | 2.9% | -8.7% | US$11.8b | US$11.29 | PB0.8x | E77.9% | 4.6% | ||
IBRX | US$2.82 | 14.2% | -27.3% | US$2.3b | US$11.40 | PS47.1x | E69.3% | n/a | ||
BRKR | US$34.54 | 6.7% | -43.8% | US$4.9b | US$46.73 | PE65.8x | E62.9% | 0.6% | ||
CYTK | US$36.88 | 7.5% | -35.4% | US$4.4b | US$72.05 | PS51.5x | E36.4% | n/a | ||
BIO | US$287.16 | 4.5% | -10.4% | US$7.3b | US$326.50 | PE24.3x | E-2.3% | n/a | ||
MDGL | US$373.46 | 4.0% | 53.5% | US$8.0b | US$449.57 | PS16.1x | E65.3% | n/a | ||
ARWR | US$19.99 | 12.3% | -11.9% | US$2.5b | US$43.79 | PS4.8x | E-13.2% | n/a | ||
TECH | US$54.71 | 3.6% | -24.8% | US$8.3b | US$64.15 | PE116.8x | E23.1% | 0.6% | ||
AVTR | US$13.07 | 3.2% | -47.9% | US$8.6b | US$14.12 | PE13x | E-8.4% | n/a | ||
BMRN | US$58.30 | 2.5% | -34.9% | US$10.9b | US$97.62 | PE17x | E17.2% | n/a | ||
ROIV | US$11.96 | 3.4% | 5.7% | US$8.2b | US$17.11 | PS351.4x | E34.0% | n/a | ||
NBIX | US$131.62 | 2.1% | -10.3% | US$12.8b | US$167.87 | PE37.5x | E26.1% | n/a |